Scynexis enacts 1-for-8 reverse stock split

SCYNEXIS, Inc. has approved and implemented a one-for-eight reverse stock split of its common stock, together with a reduction in authorized shares.

Rhea-AI Filing Summary

SCYNEXIS, Inc. has approved and implemented a one-for-eight reverse stock split of its common stock, together with a reduction in authorized shares. Effective May 29, 2026, every eight issued and outstanding shares were combined into one share, and authorized common shares were reduced from 150,000,000 to 18,750,000 with no change in par value.

The reverse split applies proportionately to all stockholders and adjusts the share counts and, where applicable, exercise prices of stock options, restricted stock units and warrants. No fractional shares will be issued; holders entitled to fractions will receive cash instead. SCYNEXIS common stock is scheduled to begin trading on Nasdaq on a split-adjusted basis on June 1, 2026 under the symbol SCYX with a new CUSIP of 811292 309.

Insights

Capital structure analyst

SCYNEXIS consolidates its share count through a 1:8 reverse split and cuts authorized stock.

SCYNEXIS adopted a 1:8 reverse stock split effective May 29, 2026, simultaneously reducing authorized common shares from 150,000,000 to 18,750,000. This consolidates the share count while keeping the par value at $0.001 per share.

The split proportionately affects all existing holders, as well as shares underlying equity compensation plans and warrants. Fractional entitlements will be settled in cash. The stock is expected to trade on a split-adjusted basis on Nasdaq starting June 1, 2026 under the existing ticker, with a new CUSIP identifying the post-split shares.

8-K Event Classification

2 items: 5.03, 9.01

2 items

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance

The company amended its charter documents, bylaws, or changed its fiscal year.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Reverse split ratio: 1-for-8 Authorized shares before: 150,000,000 shares Authorized shares after: 18,750,000 shares +4 more

7 metrics

Reverse split ratio 1-for-8 Reverse stock split of common stock effective May 29, 2026

Authorized shares before 150,000,000 shares Authorized common stock prior to amendment

Authorized shares after 18,750,000 shares Authorized common stock after amendment effective May 29, 2026

Par value per share $0.001 per share Par value of common stock unchanged by reverse split

Effective date of amendment May 29, 2026 Certificate of Amendment effectiveness for split and share reduction

Split-adjusted trading date June 1, 2026 Scheduled start of Nasdaq split-adjusted trading for SCYX

New CUSIP 811292 309 CUSIP for common stock following reverse stock split

Key Terms

reverse stock split, authorized shares, equity compensation plans, restricted stock units, +1 more

5 terms

reverse stock split financial

"to effect a one-for-eight (1:8) reverse stock split of its outstanding common stock"

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

authorized shares financial

"a reduction in the total number of authorized shares of its common stock from 150,000,000 to 18,750,000"

Authorized shares are the maximum number of shares a company is allowed to issue according to its official plan. Think of it as a company’s set limit on how many pieces of its ownership it can distribute to investors. This number helps investors understand the potential for future growth or change in the company's ownership structure.

equity compensation plans financial

"as well as the number of shares of common stock available for issuance under the Company’s equity compensation plans"

Equity compensation plans are programs that give employees or directors a stake in a company through stock, options, or restricted shares, like handing workers a slice of the ownership pie instead of only a paycheck. They matter to investors because they align staff incentives with company performance and can change the number of shares outstanding, which affects per-share earnings and shareholder value, so investors watch their size and terms closely.

restricted stock units financial

"reduction in the number of shares of common stock issuable upon the exercise of stock options, restricted stock units and warrants"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

CUSIP number financial

"The new CUSIP number for the common stock following the Reverse Stock Split is 811292 309."

A CUSIP number is a nine-character code that uniquely identifies a specific U.S. or Canadian stock, bond, or other security, similar to a barcode or a social-security number for a financial instrument. It matters to investors because it removes confusion between similar securities, ensures trades and settlements are applied to the correct issue, and helps locate official documents and transaction records quickly.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What reverse stock split did SCYNEXIS (SCYX) implement?

SCYNEXIS implemented a one-for-eight reverse stock split of its common stock. Effective May 29, 2026, every eight issued and outstanding shares automatically converted into one share, consolidating the share count while keeping the par value per share unchanged at $0.001.

How did SCYNEXIS change its authorized common shares in this 8-K?

SCYNEXIS reduced its authorized common shares from 150,000,000 to 18,750,000. This reduction became effective with the same amendment that implemented the one-for-eight reverse stock split, aligning authorized share capacity with the post-split capital structure.

Will SCYNEXIS stockholders’ ownership percentages change after the reverse split?

The reverse stock split is designed to affect all SCYNEXIS stockholders proportionately. Each holder’s percentage ownership remains the same, except where rounding creates fractional shares, which are settled in cash instead of issuing fractional post-split shares.

How are SCYNEXIS options, RSUs and warrants affected by the reverse split?

SCYNEXIS adjusted equity awards and warrants to reflect the one-for-eight split. The number of shares underlying stock options, restricted stock units and warrants was reduced, with a corresponding increase in option and warrant exercise prices, preserving the overall economic terms of those instruments.

When will SCYNEXIS trade on a split-adjusted basis and under what symbol?

SCYNEXIS common stock is scheduled to trade on a split-adjusted basis on June 1, 2026. The shares will continue under the existing Nasdaq ticker SCYX but will carry a new post-split CUSIP number, 811292 309.

How will SCYNEXIS handle fractional shares from the reverse stock split?

SCYNEXIS will not issue fractional shares created by the reverse split. Stockholders who would otherwise receive a fractional post-split share will instead receive a cash payment in lieu of that fractional interest, simplifying the share structure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/29/2026 - 04:01 PM Learn about SEC filing dates

0001178253--12-31false00011782532026-05-282026-05-28

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 28, 2026

SCYNEXIS, Inc.

(Exact name of Registrant as Specified in Its Charter)

Delaware			001-36365	56-2181648
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
1 Evertrust Plaza 13th Floor
Jersey City, New Jersey				07302-6548
(Address of Principal Executive Offices)				(Zip Code)

Registrant’s Telephone Number, Including Area Code: 201 884-5485

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.001 per share		SCYX		The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.03. Amendments to Articles of Incorporation or Bylaws.

On May 28, 2026, SCYNEXIS, Inc., a Delaware corporation (the “Company”), filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Amendment”), to effect a one-for-eight (1:8) reverse stock split of its outstanding common stock (the “Reverse Stock Split”) and a reduction in the total number of authorized shares of its common stock from 150,000,000 to 18,750,000, effective as of May 29, 2026 (the “Share Reduction”). A series of alternate amendments to effect the Reverse Stock Split and a reduction in the total number of the authorized shares of the Company’s common stock was approved by the Company’s stockholders at a Special Meeting of Stockholders held on May 19, 2026, and the specific one-for-eight (1:8) ratio and the corresponding Share Reduction was subsequently approved by the Company’s Board of Directors on May 19, 2026.

The Amendment provides that, at the effective time of the Amendment, every eight (8) shares of the Company’s issued and outstanding common stock was automatically converted into one issued and outstanding share of common stock and the authorized shares of the Company’s common stock was reduced from 150,000,000 to 18,750,000, without any change in par value per share. The Reverse Stock Split affected all shares of the Company’s common stock outstanding immediately prior to the effective time of the Amendment, as well as the number of shares of common stock available for issuance under the Company’s equity compensation plans. In addition, the Reverse Stock Split effected a reduction in the number of shares of common stock issuable upon the exercise of stock options, restricted stock units and warrants outstanding immediately prior to the effectiveness of the Amendment with a corresponding increase in the exercise price per share applicable to such stock options and warrants.

No fractional shares were issued because of the Reverse Stock Split. Stockholders who would otherwise be entitled to receive a fractional share will receive a cash payment in lieu thereof. The Reverse Stock Split affected all stockholders proportionately and will not affect any stockholder’s percentage ownership of the Company’s common stock (except to the extent that the Reverse Stock Split results in any stockholder owning only a fractional share).

The Company’s common stock is scheduled to begin trading on the Nasdaq Capital Market on a split-adjusted basis when the market opens on June 1, 2026 under the existing ticker symbol “SCYX”. The new CUSIP number for the common stock following the Reverse Stock Split is 811292 309. The par value per share of the common stock will remain unchanged at $0.001.

The foregoing description is qualified in its entirety by the Amendment, which is attached as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
3.1		Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant.
100		Cover Page Interactive Data File (formatted as Inline XBRL).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			SCYNEXIS, Inc.
Date:	May 29, 2026	By:	/s/ David Angulo, M.D.
		Name:	David Angulo, M.D.
		Title:	Chief Executive Officer

Filing Exhibits & Attachments

2 documents

Other Documents

• EX-3.1 EX-3.1 15.9 KB
• EX-101 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 31.1 KB